What is Dr. Zubair Khalid's research focus?

Dr. Zubair Khalid specializes in molecular virology, mRNA vaccine development, and computational biology, with a focus on avian pathogens like IBDV and Avian Reovirus.

Where is Dr. Zubair Khalid currently working?

Dr. Zubair Khalid is a Postdoctoral Research Associate at the University of Maryland (UMD), specifically within the Department of Animal and Avian Sciences.

Connective Tissue Disorders: Types and Mechanisms

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-09-20

Connective tissue disorders are a group of inherited or acquired conditions in which the extracellular matrix that holds skin, joints, blood vessels, and bone together is structurally or biochemically defective. They arise most often from faults in collagen (types I, III, and V), elastin, or fibrillin, the proteins that give connective tissue its tensile strength, elasticity, and load-bearing capacity.

These conditions matter because connective tissue is everywhere. The same protein defect that makes skin hyperextensible in a dog can thin an aortic wall in a person or fracture a long bone in a child. Learning to separate the inherited causes from the acquired ones, and to match each disorder to its defective protein, is the fastest route to a correct diagnosis in both human and veterinary medicine.

The Extracellular Matrix: What Connective Tissue Actually Is

Connective tissue is not a single tissue. It is a family of tissues built on the same scaffold: cells scattered through an extracellular matrix (ECM), the non-cellular material that surrounds and supports cells. That matrix has two main components.

The first is the fibrous protein network. Collagen provides tensile strength, the resistance to being pulled apart. Elastin and fibrillin microfibrils provide elasticity, the ability to stretch and recoil. The second component is ground substance, a hydrated gel of proteoglycans and glycosaminoglycans that resists compression and organizes the fibers.

Fibroblasts are the cells that build most of this matrix. They secrete collagen as a precursor called procollagen, which carries extra peptide extensions at both ends. Enzymes trim those extensions so the molecules can assemble into fibrils. One of those trimming enzymes is ADAMTS2, a procollagen N-proteinase [1]. When ADAMTS2 fails, procollagen never matures properly, and the resulting fibrils are malformed.

Collagen fibrils are not uniform rods. They are heterotypic structures, meaning more than one collagen type builds them. Type I collagen forms the bulk of the fibril, while type V collagen sits at the core and controls how the fibril nucleates and grows. That is why a defect in type V collagen, not type I, produces classical Ehlers-Danlos syndrome: the scaffolding is present, but the fibrils are disorganized [2][3].

Why Protein Type Determines Disease Type

The clinical picture of a connective tissue disorder follows directly from which protein is defective and where that protein is expressed.

Type I collagen dominates bone, tendon, dentin, and mature skin. Defects cause fragile bones (osteogenesis imperfecta).
Type III collagen dominates blood vessels, hollow organs, and fetal skin. Defects cause vascular Ehlers-Danlos syndrome, with arterial and organ rupture [4][5].
Type V collagen regulates fibril assembly in skin. Defects cause classical Ehlers-Danlos syndrome, with hyperextensible skin and poor wound healing [2][6][7].
Fibrillin-1 forms microfibrils in the aorta and suspensory ligament of the lens. Defects cause Marfan syndrome, with aortic root dilation and lens dislocation [8][9].

Inherited Versus Acquired Causes

The distinction between inherited and acquired connective tissue disorders is the first branch point in any diagnostic reasoning.

Inherited disorders result from germline variants in a matrix gene. They are present from conception, though signs may not appear until a tissue is stressed. Marfan syndrome is autosomal dominant, so one altered FBN1 copy is enough [8]. Dermatosparactic Ehlers-Danlos syndrome is autosomal recessive and requires two altered ADAMTS2 copies [10][1]. Vascular Ehlers-Danlos syndrome is autosomal dominant with heterozygous COL3A1 mutations [5].

Acquired disorders develop during life. The matrix is damaged by an external agent, an immune process, or a metabolic disturbance. A clear veterinary example comes from a mouse model of vascular Ehlers-Danlos syndrome: ciprofloxacin exposure decreased aortic collagen content, decreased lysyl oxidase, increased matrix metalloproteinases 2 and 9, and increased macrophage infiltration, and 44% of treated vEDS mice died of aortic or arterial rupture within the four-week study period [4]. The genetic defect was inherited, but the rupture event was triggered by a drug. This is the clearest illustration that inherited predisposition and acquired insult can combine.

Acquired connective tissue disease also includes scurvy (vitamin C deficiency impairs collagen hydroxylation), autoimmune conditions that attack matrix components, and age-related elastin degradation. The mechanism differs from inherited disease, but the downstream tissue failure is similar.

Ehlers-Danlos Syndrome: Collagen Defects

Ehlers-Danlos syndromes (EDS) are a heterogeneous group of heritable connective tissue disorders, most commonly linked to collagen abnormalities [11]. The hallmark triad is skin hyperextensibility, joint hypermobility, and tissue fragility.

Classical EDS (Types V and I Collagen)

Classical EDS is caused primarily by mutations in COL5A1 or COL5A2, the genes for type V collagen [2][3][7]. Type V collagen regulates the diameter and spacing of type I collagen fibrils. When it is deficient, fibrils assemble abnormally.

A murine model with conditional loss of Col5a1 in fibroblasts showed an abnormal ECM with fibrillar disarray, altered mechanical properties, and decreased collagen deposition [2]. The same model showed decreased expression of epidermal genes and increased inflammation, and wound healing improved when mechanosensitive integrin signaling was blocked or wild-type fibroblasts were injected [2].

In cats, whole genome sequencing identified a novel splice acceptor site variant at exon 4 in COL5A1 (c.501-2A>C) in a cat with skin hyperextensibility and fragility [6]. A separate study found three independent heterozygous COL5A1 variants in four affected cats, all predicted to cause nonsense-mediated mRNA decay and haploinsufficiency [3]. In dogs, six distinct heterozygous COL5A1 variants were identified across seven dogs, with fragile skin, hyperextensible skin, joint hypermobility, and atrophic scars as the most common signs [7].

Vascular EDS (Type III Collagen)

Vascular EDS is caused by heterozygous mutations in COL3A1, the gene for type III collagen [5]. Type III collagen is abundant in arteries, so the dominant risk is arterial dissection and rupture.

Mouse models carrying Col3a1 mutations recapitulate the vascular phenotype and die suddenly of aortic rupture [5]. One study found that C57BL6/J mice with the Col3a1 G938D mutation were susceptible, while 129S6/SvEvTac mice with the same mutation were nearly completely protected, and the protective locus mapped to Map2k6, a p38-activating kinase [5]. This shows that genetic background modifies vascular risk independently of the primary collagen defect.

Another Col3a1 knock-in model showed thin, non-inflammatory arteries with altered arterial collagen, and transcriptomic analysis showed upregulation of inflammation and cell stress genes [12]. Losartan had a beneficial effect on survival that reversed when administration stopped, while exogenous angiotensin II was markedly deleterious [12].

Dermatosparactic EDS (ADAMTS2)

Dermatosparactic EDS is autosomal recessive and caused by biallelic ADAMTS2 mutations [10][1]. ADAMTS2 encodes procollagen I N-proteinase. Without it, procollagen cannot be trimmed to mature collagen.

Affected dogs show extreme skin fragility. In one report, six dogs with a homozygous ADAMTS2 deletion had multifocal wounds, atrophic scars, joint hypermobility, narrowed palpebral fissures, and skin hyperextensibility, and all were euthanized before 13 weeks of age because of severe skin fragility [1]. Cross sections of dermal collagen fibrils showed hieroglyphic-like figures, a characteristic ultrastructural pattern [1].

A milder form exists. A nearly 10-year-old Catahoula Leopard dog with a homozygous ADAMTS2 missense variant had reduced collagen fiber density and variable fibril diameters but lacked the hieroglyphic appearance seen with the frameshift variant [13]. This shows that the same gene can produce very different severities depending on the specific variant.

In cats, a one base pair duplication causing a frameshift in ADAMTS2 (p.(Ser235fs*3)) was identified in four kittens with easily torn skin and nonhealing wounds. All four were homozygous, and the variant cosegregated with the autosomal recessive phenotype [10].

Musculocontractural EDS (Dermatan Sulfate Pathway)

Musculocontractural EDS is caused by mutations in CHST14 or DSE, which disrupt dermatan sulfate biosynthesis [14][15]. Dermatan sulfate chains on decorin proteoglycan are replaced by chondroitin sulfate, which disorganizes collagen networks in skin [14].

Electron microscopy of mcEDS-CHST14-mimicking collagen gels showed impaired fibrillar organization and weaker mechanical strength [14]. Mouse models show suppressed growth, skin fragility with collagen fibril deformation, thoracic kyphosis, hypotonia, and myopathy [15].

Tenascin-X and Other Non-Collagen EDS Forms

Not all EDS involves collagen. A Maltese dog with an Ehlers-Danlos-like syndrome had minimal collagen alterations but elastic fiber hypertrophy and fragmentation, a pattern consistent with possible Tenascin-X deficiency [11]. The dog had progressive abdominal masses, skin fragility, joint deformities, and frequent bruising, and died within ten days of initial consultation from spontaneous evisceration and vascular rupture [11].

A separate novel form of EDS with vascular features was linked to a heterozygous THBS2 pathogenic variant. Affected individuals had joint hypermobility, frequent dislocations, atrophic scarring, prolonged bleeding time, and age-related aortic dilation and rupture, with disorganized reticular dermis collagen on histology [16].

Marfan Syndrome: Fibrillin-1 Defects

Marfan syndrome is an autosomal dominant connective tissue disorder caused by mutations in FBN1, the gene encoding fibrillin-1, the main component of extracellular microfibrils [8]. In the aortic wall, these microfibrils maintain structural integrity and sustain hemodynamic load [8].

The major cause of morbidity and mortality in Marfan syndrome is progressive aortic aneurysm and dissection [8]. Atomic force microscopy of individual aortic fibrillin-1 microfibrils from Marfan patients showed preserved overall pattern and periodicity but morphological irregularities in microfibril beads and interbead segments, consistent with structural fragility [8]. Force spectroscopy showed reduced transverse elastic modulus in patients with haploinsufficient FBN1 variants, and nanoindentation showed localized deformation at markedly lower forces in Marfan microfibril beads, indicating diminished load-bearing capacity [8].

Research models include induced pluripotent stem cell lines generated from three Marfan patients carrying FBN1 mutations (c.6554 T>C, c.4425-4426delinsC, and c.6806 T>C), which provide a cellular system for studying the cardiovascular pathology [9].

Marfan syndrome is often confused with vascular Ehlers-Danlos syndrome because both affect the aorta. The distinction is the protein. Marfan is a fibrillin-1 microfibril problem. Vascular EDS is a type III collagen problem. The tissues affected overlap, but the molecular mechanism and the pattern of extracardiac signs differ.

A related condition, ADAMTS6 loss-of-function, impairs processing of fibrillin-1 and fibrillin-2, causing microfibril disorganization. Affected individuals showed phenotypes ranging from early-onset syndromic presentations with cardiovascular, craniofacial, skeletal, and neurodevelopmental involvement to isolated adult-onset heritable thoracic aortic aneurysm and dissection [17].

Osteogenesis Imperfecta: Type I Collagen Defects

Osteogenesis imperfecta is the type I collagen disorder. Type I collagen is the dominant protein of bone, so the primary sign is bone fragility. Where Ehlers-Danlos syndrome shows hyperextensible skin and joint laxity, osteogenesis imperfecta shows fractures from minimal trauma. Both can involve blue sclera and hearing loss, but the tissue that fails first is different.

The mechanism is straightforward: if the main structural protein of bone is defective or underproduced, bone mineral cannot be laid down on a sound scaffold. The result is a bone that looks normal on imaging but breaks under loads a healthy bone would tolerate.

Classification Table: Defective Protein, Gene, Hallmark Sign, and Species Example

Disorder	Defective protein	Gene	Hallmark sign	Species example
Classical EDS	Type V collagen	COL5A1, COL5A2	Hyperextensible, fragile skin, joint hypermobility	Dogs [7], cats [6][3]
Vascular EDS	Type III collagen	COL3A1	Arterial and organ rupture	Mice [4][5][12]
Dermatosparactic EDS	Procollagen I N-proteinase	ADAMTS2	Extreme skin fragility, hieroglyphic fibrils	Dogs [13][1], cats [10], cattle and sheep [10]
Musculocontractural EDS	Dermatan sulfate pathway	CHST14, DSE	Congenital malformations, progressive fragility	Mice [14][15]
Marfan syndrome	Fibrillin-1	FBN1	Aortic root dilation, lens dislocation	Humans [8][9]
ADAMTS6 deficiency	ADAMTS6 (fibrillin processing)	ADAMTS6	Thoracic aortic aneurysm, craniofacial and skeletal signs	Humans, mice [17]
THBS2-related EDS	Thrombospondin-2	THBS2	Joint hypermobility with vascular features	Humans, mice [16]
Osteogenesis imperfecta	Type I collagen	COL1A1, COL1A2	Fragile bones, fractures from minimal trauma	Textbook knowledge
Cutaneous asthenia	Collagen (often type V) or elastin	COL5A1 and others	Hyperextensible, easily torn skin	Dogs, cats [11][18]
Bovine dermatosparaxis	Procollagen I N-proteinase	ADAMTS2	Skin fragility, torn hide	Cattle, sheep [10][18]

How These Disorders Are Tested and Observed

Diagnosis of connective tissue disorders combines clinical examination, histopathology, electron microscopy, and molecular testing.

Clinical examination looks for skin hyperextensibility, joint hypermobility, atrophic scarring, and bruising. In dogs and cats, the classic presentation is a young animal with thin, hyperextensible skin that tears easily and heals with atrophic scars [18].

Histopathology shows disorganized and fragmented collagen fibrils on light microscopy [18]. In classical EDS in a cat, histology showed sparse, disorganized collagen and an increase in cutaneous mast cells [6]. In dermatosparactic EDS in dogs, light microscopy showed substantially reduced density of collagen fibers that were randomly oriented and appeared to have decreased length [13].

Electron microscopy adds ultrastructural detail. Flower-like collagen fibrils in cross-section are characteristic of COL5A1 variants [6]. Hieroglyphic-like figures in collagen fibril cross sections are characteristic of severe dermatosparaxis [1]. Variable fibril diameters and irregular cross-sectional profiles appear in milder ADAMTS2 missense cases [13].

Molecular testing confirms the diagnosis. Whole genome sequencing identified the COL5A1 splice acceptor variant in a cat [6], the ADAMTS2 frameshift in a cat family [10], and COL5A1 variants in dogs [7]. In human medicine, exome and genome sequencing identified ADAMTS6 variants in four unrelated individuals with syndromic or isolated vascular disease [17].

For Marfan syndrome, nanomechanical testing by atomic force microscopy reveals reduced transverse elastic modulus and diminished load-bearing capacity in fibrillin-1 microfibrils, which correlates with genotype [8].

Veterinary Relevance: Cutaneous Asthenia and Dermatosparaxis

Connective tissue disorders occur in domestic animals, though they remain uncommon [18]. Ehlers-Danlos syndrome was described in dogs as early as 1943 and later in cats [18].

In dogs and cats, the condition is often called cutaneous asthenia, meaning skin weakness. The involved skin is thin and hyperextensible, with easily inflicted injuries that result in hemorrhagic wounds and atrophic scars [18]. Joint laxity and dislocation, which are common in people, are less frequently found in dogs [18]. Serious systemic complications such as organ rupture or cardiovascular problems, which have devastating consequences in people, have not been described in cats and dogs [18].

Bovine dermatosparaxis is the cattle and sheep equivalent of human Ehlers-Danlos syndrome type VIIC. It is caused by mutations in the procollagen I N-proteinase (pnPI) or ADAMTS2 gene, though mutations at other sites are likely responsible for other types of dermatosparaxis [18]. The same ADAMTS2 loss-of-function mechanism causes autosomal recessive EDS in humans, mice, dogs, cattle, and sheep [10].

Cutaneous asthenia is not limited to dogs and cats. A Campbell's dwarf hamster with hyperextensible skin, glaucoma, and lens dislocation showed irregular, haphazard arrangement of collagen fibers in the dermis on histopathology [19].

Common Mistakes and Limitations

The first common mistake is assuming that hyperextensible skin always means Ehlers-Danlos syndrome. A Maltese dog with an Ehlers-Danlos-like syndrome had primarily elastic fiber abnormalities rather than collagen defects, consistent with possible Tenascin-X deficiency [11]. Elastic fiber disorders and collagen disorders can look similar on physical examination.

The second mistake is treating all EDS as one disease. Classical EDS, vascular EDS, dermatosparactic EDS, and musculocontractural EDS have different genes, different inheritance patterns, and different risks [14][2][15][10][5][1]. A diagnosis of "EDS" without a subtype is incomplete.

The third mistake is assuming that a genetic defect alone determines outcome. The Map2k6 modifier locus shows that genetic background can nearly abolish vascular rupture risk in mice carrying the same Col3a1 mutation [5]. Environmental exposures such as ciprofloxacin can also trigger rupture in genetically susceptible animals [4].

The fourth mistake is expecting the same clinical severity across species. Joint laxity and systemic complications are less frequent in dogs than in people with comparable collagen defects [18].

A limitation of current knowledge is that many cases remain unclassified at the molecular level. The Maltese dog case could not be definitively classified because molecular testing was beyond the scope of the report [11]. In human medicine, a large proportion of heritable thoracic aortic aneurysm and dissection cases remain idiopathic despite sequencing [17].

Quick Review

Connective tissue disorders arise from defects in collagen (types I, III, V), elastin, or fibrillin.
Inherited causes involve germline gene variants. Acquired causes involve damage during life, such as drug exposure or nutritional deficiency.
Classical EDS is a type V collagen disorder with hyperextensible skin and joint laxity.
Vascular EDS is a type III collagen disorder with arterial and organ rupture risk.
Marfan syndrome is a fibrillin-1 disorder with aortic root dilation and lens dislocation.
Osteogenesis imperfecta is a type I collagen disorder with fragile bones.
Dermatosparactic EDS is an ADAMTS2 disorder with extreme skin fragility and hieroglyphic collagen fibrils.

Frequently Asked Questions

What is the main difference between Ehlers-Danlos syndrome and Marfan syndrome?

Ehlers-Danlos syndrome is primarily a collagen disorder, while Marfan syndrome is a fibrillin-1 disorder. Ehlers-Danlos typically presents with hyperextensible skin and joint hypermobility, while Marfan syndrome presents with aortic root dilation and lens dislocation.

Can dogs and cats get connective tissue disorders?

Yes. Dogs and cats can develop Ehlers-Danlos syndrome, often called cutaneous asthenia, with thin, hyperextensible skin that tears easily [18]. Classical EDS in dogs is linked to COL5A1 variants, and dermatosparactic EDS is linked to ADAMTS2 variants [7][1].

What is bovine dermatosparaxis?

Bovine dermatosparaxis is a connective tissue disorder in cattle and sheep caused by mutations in the procollagen I N-proteinase (pnPI) or ADAMTS2 gene [18]. It is the animal equivalent of human Ehlers-Danlos syndrome type VIIC and produces skin fragility.

Why do different collagen types cause different diseases?

Each collagen type has a different tissue distribution and structural role. Type I collagen dominates bone, type III collagen dominates blood vessels, and type V collagen regulates fibril assembly in skin. A defect in each type therefore produces a different pattern of tissue failure.

Is Ehlers-Danlos syndrome always inherited?

Most Ehlers-Danlos syndromes are inherited, but acquired factors can worsen or trigger complications. Ciprofloxacin exposure increased aortic rupture risk in a mouse model of vascular EDS even though the underlying Col3a1 mutation was inherited [4].

What does "hieroglyphic" collagen mean in dermatosparaxis?

Hieroglyphic collagen refers to an abnormal cross-sectional appearance of collagen fibrils seen on electron microscopy in severe dermatosparaxis. It was observed in dogs with a homozygous ADAMTS2 frameshift variant and is characteristic of severe disease [1].